Northern Trust’s Turnstone Biologics TSBX Stock Holding History

Northern Trust’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-18,405	Closed	-$6.61K	–	4538
2025 Q2	$6.61K	Hold	18,405	–	–	﹤0.01%	4384
2025 Q1	$7.55K	Hold	18,405	–	–	﹤0.01%	4403
2024 Q4	$9.14K	Hold	18,405	–	–	﹤0.01%	4426
2024 Q3	$10.3K	Sell	18,405 -75,829	-80%	-$116K	﹤0.01%	4379
2024 Q2	$247K	Sell	94,234 -5,241	-5%	-$15K	﹤0.01%	3786
2024 Q1	$261K	Buy	99,475 +34,403	+53%	+$98.5K	﹤0.01%	3803
2023 Q4	$166K	Buy	65,072 +7,290	+13%	+$19K	﹤0.01%	3962
2023 Q3	$228K	Buy	+57,782	New	+$515K	﹤0.01%	3759

Northern Trust's TSBX Position: Q3 2025 in Review

Northern Trust sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 18,405 shares — an estimated $6.61K sold.

Northern Trust first reported a position in TSBX in Q3 2023 and held it in 8 quarters. The position peaked at $261K in Q1 2024. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

Northern Trust reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
Northern Trust sold 18,405 Turnstone Biologics shares in Q3 2025, an estimated $6.61K.
Northern Trust first reported a position in Turnstone Biologics in Q3 2023 and held it in 8 quarters.
Northern Trust's Turnstone Biologics position peaked at $261K in Q1 2024.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on Northern Trust's 13F filing for Q3 2025, filed 14 Nov 2025.